Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Organigram Global Inc. - Common Shares (NQ:OGI)

0.8401 -0.0136 (-1.59%)
Delayed Quote Updated: 9:44 AM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Organigram Global Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
News headline image
The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf ↗
Organigram is valuing Aurora Cannabis more highly than Curleaf, but that doesn't mean it's the best option for shareholders in the long run. 
Via The Motley Fool
Topics Cannabis
News headline image
Organigram Global Targets Profitable Growth With Canada Focus and German Expansion ↗
Organigram Global (NASDAQ:OGI) outlined a strategy centered on protecting its Canadian market position while increasing profitability, expanding internationally through its Sanity Group acquisition,... 
Via MarketBeat
Topics Cannabis
Cannabis Stocks: A Profitability Turnaround Is Brewing Beneath Weak Price Action ↗
Via Chartmill
Topics Cannabis
News headline image
Organigram (OGI) Q3 2026 Earnings Call Transcript ↗
Revenue jumped 49% to $105.8 million on Sanity acquisition. 
Via The Motley Fool
Topics Earnings
Small-Cap Cannabis Stocks Surge, but Big-Cap Laggards Reveal a Narrow, Speculative Rally ↗
Via Chartmill
Topics Cannabis
News headline image
OrganiGram Holdings's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Organigram Global Q3 Earnings Call Highlights ↗
Organigram Global (NASDAQ:OGI) reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, aided by the consolidation of Germany-based Sanity Group and improving performance in several... 
Via MarketBeat
Topics Cannabis Earnings
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global... 
Via Benzinga
News headline image
Organigram Global Q2 Earnings Call Highlights ↗
Organigram Global (NASDAQ:OGI) reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues in key product categories, softer Canadian cannabis market... 
Via MarketBeat
Topics Cannabis Earnings
News headline image
4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill ↗
Cannabis stocks TLRY, CRON, OGI, and SNDL log momentum gains even as Congress moves to re-criminalize some hemp-derived THC products. 
Via Benzinga
Topics Cannabis
News headline image
Earnings Scheduled For May 12, 2025 ↗
 
Via Benzinga
News headline image
Insights Ahead: OrganiGram Holdings's Quarterly Earnings ↗
 
Via Benzinga
News headline image
OrganiGram (OGI) Joins Cannabis Stock Rally After Trump Signals Policy Shift ↗
Organigram Global Inc (NASDAQ: OGI) shares are trading sharply higher Monday afternoon, joining a rally across the cannabis sector. 
Via Benzinga
Topics Cannabis Government
News headline image
Organigram Posts Wider Loss, Eyes Profitability In Near Term ↗
Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected. 
Via Benzinga
News headline image
Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 9, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For July 2, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Earnings Scheduled For August 13, 2025 ↗
 
Via Benzinga
News headline image
Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Hemp, Hope And Hard Truths: A New Era Of Realism At Benzinga's Chicago Summit ↗
Benzinga's 2025 cannabis conference revealed realism, reform hopes, and a hemp showdown. Jesse Redmond, Todd Harrison & others weigh in. 
Via Benzinga
Topics Cannabis
News headline image
Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 11, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
EXCLUSIVE: Tobacco Sector Looks To Cannabis For Growth: 'Investments Are Meant For A Very Specific Reason' ↗
Big tobacco companies have made small investments in the cannabis space. Industry experts share with Benzinga what could be next for partnerships and investments. 
Via Benzinga
Topics Cannabis
News headline image
THC Drinks Aren't The New Beer, They're Something Else, Says Tilray ↗
Tilray is building a new adult beverage category with hemp THC drinks, as alcohol declines and competition from Big Tobacco heats up. 
Via Benzinga
News headline image
Organigram CEO To Retire After Building Canada's Largest Cannabis Brand: Here's What's Next ↗
Organigram CEO Beena Goldenberg to retire after leading company to #1 in Canada and launching U.S. and global expansion plans. 
Via Benzinga
Topics Cannabis
News headline image
Germany Has Become The World's Largest Cannabis Importer: Here Are The Stocks Benefiting ↗
Germany became the world's top importer of medical cannabis, but political pressure could challenge telehealth-driven growth. 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For May 21, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From May 19, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
This Week In Cannabis: Earnings Season, Uruguay's 'Pepe' Mujica's Legacy, DEA's Meme Backlash, California's Tax Hike, The DEA's Stance And More ↗
Cannabis jobs fall while sales rise, Mujica's death sparks global reflection, and the DEA returns to old scare tactics. This week's top cannabis news. 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For May 12, 2025 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn ↗
Organigram's Q2 sales surged 74% to $45.7 million, driven by Motif and global growth, with net income swinging to CA$42.5 million from a loss a year ago. 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From May 6, 2025 ↗
 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.